Bryan Farley

Bryan Farley is an accomplished professional with extensive experience in the biopharmaceutical industry, currently serving as VP CMC / External Manufacturing at Beam Therapeutics since August 2020, overseeing CMC for the hematology, liver, and immunology portfolios and managing a network of over 10 external partners. Previous roles include Director Manufacturing Technical Operations at Takeda, where Bryan built a process engineering team and led automation efforts, and key positions at Shire, including Director Downstream Manufacturing Capacity Expansion and Director Production Technical Support, contributing to significant manufacturing network strategies and process transfers. Early career experiences include roles at Biogen, Amgen, and Sigma-Aldrich, highlighting expertise in process development and technical support. Bryan holds an MBA in International Business from Thunderbird School of Global Management and a BS in Cellular Biology with a minor in Chemistry from Penn State University.